Picture Berlin Partner Special Topic Well-trained Professionals 650x100px

News > All

Total search results: 9760 | Ordered by Date (descending)
1 2 3 ... 96 97 98  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Merck KGaA. (12/5/23). "Press Release: Merck Launches First Ever AI Solution to Integrate Drug Discovery and Synthesis". Darmstadt. 2023-12-05
IBM Corporation. (12/5/23). "Press Release: AI Alliance Launches as an International Community of Leading Technology Developers, Researchers, and Adopters Collaborating Together to Advance Open, Safe, Responsible AI". 2023-12-05
Thermosome GmbH. (12/5/23). "Press Release: Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronchi, MD, to Clinical Advisory Board". Munich. 2023-12-05
Exscientia plc. (12/5/23). "Press Release: Exscientia Receives Open Philanthropy Grant to Explore New Therapeutic Approach for Pandemic Influenza". Oxford. 2023-12-05
Eligo Bioscience S.A.. (12/5/23). "Press Release: Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines". Paris. 2023-12-05
Aqemia S.A.S.. (12/5/23). "Press Release: Aqemia Announces a Major Multi-year Collaboration of $140 Million with Sanofi". Paris. 2023-12-05
Ion Beam Applications S.A. (IBA). (12/5/23). "Press Release: IBA Signs Research Collaboration Agreement with the University of Kansas Medical Center on FLASH Technology". Louvain-la-Neuve. 2023-12-05
Sofinnova Partners. (12/5/23). "Press Release: Sofinnova Partners Unveils Sofinnova.AI – a Cutting-edge Artificial Intelligence Platform Set to Transform Its Life Sciences Investment practice". Paris. 2023-12-05
Merck KGaA. (12/4/23). "Press Release: Merck Strengthens Oncology Portfolio through Commercialization Agreement With Abbisko for Phase III Asset, Pimicotinib [Not intended for UK-, US- or Canada-based media]". Darmstadt. 2023-12-04
Roche. (12/4/23). "Press Release: Roche Enters into a Definitive Merger Agreement to Acquire Carmot Therapeutics, including Three Clinical Stage Assets with Best-in-class Potential in Obesity and Diabetes". Basel. 2023-12-04
Refeyn Ltd.. (11/30/23). "Press Release: Refeyn Launches KaritroMP for Rapid and Reproducible Characterization of Large Viral Vectors". Oxford. 2023-11-30
Boehringer Ingelheim. (11/28/23). "Press Release: Boehringer Ingelheim and IBM Collaborate to Advance Generative AI and Foundation Models for Therapeutic Antibody Development". Ingelheim & Armonk, NY. 2023-11-28
WMT AG. (11/28/23). "Press Release: FS Investment Acquires a Stake in WMT AG". Düsseldorf & Heidelberg. 2023-11-28
AAX Biotech AB. (11/28/23). "Press Release: AAX Biotech Forms Strategic Collaboration with Oblique Therapeutics for Therapeutic Antibody Development". 2023-11-28
Evomedis GmbH. (11/23/23). "Press Release: Evomedis Announces Strategic Partnership with Medical University of Graz and COREMED Graz to Foster Wound Healing Innovation". Graz. 2023-11-23
Boehringer Ingelheim. (11/22/23). "Press Release: Boehringer Ingelheim Expands Immuno-oncology Portfolio with the Acquisition of Bacterial Cancer Therapy Specialist T3 Pharma". Ingelheim & Basel. 2023-11-22
Freeline Therapeutics Holdings plc. (11/22/23). "Press Release: Syncona to Acquire Freeline Therapeutics". London. 2023-11-22
Merck & Co., Inc.. (11/21/23). "Press Release: Merck to Acquire Caraway Therapeutics, Inc.". Rahway, NJ & Cambridge, MA. 2023-11-21
Medigene AG. (11/21/23). "Press Release: Medigene AG Announces Prioritization of Pipeline and Resource Allocation as Well as Extension of Cash Runway". Planegg. 2023-11-21
Swiss Centre for Applied Human Toxicology (SCAHT). (11/21/23). "Press Release: Prof Dr Ellen Fritsche Has Been Appointed as New Director of the Swiss Centre for Applied Human Toxicology (SCAHT)". 2023-11-21
ECBF Management GmbH. (11/21/23). "Press Release: 17 Million Euros for Sustainable Agriculture. ECBF Leads RED Horticulture Series A Financing Round, Together with Demeter IM and Unigrains". Luxembourg. 2023-11-21
GenSight Biologics S.A.. (11/21/23). "Press Release: GenSight Biologics Announces a Successful Offering for an Amount of approximately €4.7 Million". Paris. 2023-11-21
Genentech, Inc.. (11/21/23). "Press Release: Genentech and Nvidia Enter Into Strategic AI Research Collaboration to Accelerate Drug Discovery and Development". South San Francisco, CA. 2023-11-21
Bioxodes S.A.. (11/21/23). "Press Release: Bioxodes Closes €12 Million in Series A Funding Round". Gosselies. 2023-11-21
Quotient Therapeutics. (11/21/23). "Press Release: Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics". Cambridge, MA. 2023-11-21
Exscientia plc. (11/21/23). "Press Release: Exscientia to Present at the 6th Annual Evercore ISI HealthCONx Conference". Oxford. 2023-11-21
InDex Pharmaceuticals Holding AB. (11/21/23). "Press Release: InDex Pharmaceuticals Discontinues Cobitolimod Phase III Program". 2023-11-21
Merck KGaA. (11/21/23). "Press Release: Merck Expands Newest Biologics Testing Center in Shanghai". Shanghai. 2023-11-21
Recipharm AB. (11/21/23). "Press Release: Marc Funk to Transition to Recipharm's Board of Directors; Greg Behar Appointed New CEO; Inhaled Business to Standalone in 2024". 2023-11-21
Evolva Holding S.A.. (11/21/23). "Press Release: Evolva Enters into an Agreement to Sell Its Operations to Lallemand, Securing the Best Possible Outcome for the Company and Its Stakeholders". Reinach. 2023-11-21
GenSight Biologics S.A.. (11/20/23). "Press Release: GenSight Biologics Announces Launch of an Offering for an Indicative Amount of €5 Million that Has Received Subscription Commitments from New and Existing Shareholders Totaling €4 Million". Paris. 2023-11-20
Eli Lilly and Company. (11/17/23). "Press Release: Lilly Extends Tender Offer to Acquire Point Biopharma to Dec. 1, 2023". Indianapolis, IN. 2023-11-17
Eli Lilly and Company. (11/17/23). "Press Release: Lilly to Expand Injectable Manufacturing Capacity with Planned $2.5 Billion Site in Germany". Indianapolis, IN. 2023-11-17
eXmoor Pharma Concepts Ltd.. (11/16/23). "Press Release: eXmoor Appoints Matthew Paterson as First Chief Commercial Officer". Bristol. 2023-11-16
Memo Therapeutics AG. (11/16/23). "Press Release: Memo Therapeutics AG Appoints Erik van den Berg as Chief Executive Officer". Schlieren. 2023-11-16
Gilde Healthcare Partners. (11/15/23). "Press Release: Gilde Healthcare Closes New Venture&Growth Fund at €740 Million Hard Cap". Utrecht. 2023-11-15
Mainz Biomed N.V.. (11/15/23). "Press Release: Mainz Biomed Announces Closing of $5.0 Million Registered Direct Offering". Berkeley, CA & Mainz. 2023-11-15
T-Therapeutics Ltd.. (11/15/23). "Press Release: T-Therapeutics Raises £48 Million Series A for Development of Next Generation TCR Therapeutics to Transform Cancer Treatment". Cambridge. 2023-11-15
NMD Pharma A/S. (11/15/23). "Press Release: NMD Pharma Raises €75 Million (~$80 million) in a Series B Financing". Aarhus. 2023-11-15
Evolva Holding S.A.. (11/14/23). "Press Release: Evolva and Breko Broaden Partnership by Signing Agreement for the Exclusive Distribution of Veri-te Resveratrol in Germany, Austria, Thailand and Vietnam". Reinach. 2023-11-14
Nouscom AG. (11/14/23). "Press Release: Nouscom Raises €67.5 million ($72 million) in Oversubscribed Series C Financing Round". Basel. 2023-11-14
Autifony Therapeutics Ltd.. (11/14/23). "Press Release: Autifony Announces Exclusive Global License and Collaboration Agreement with Jazz Pharmaceuticals on Two Ion Channel Targets for Neurological Disorders". Stevenage. 2023-11-14
Almirall S.A.. (11/14/23). "Press Release: Almirall and Absci Announce AI Drug Discovery Partnership to Rapidly Develop Novel Treatments for Dermatological Diseases". Barcelona & Vancouver, WA. 2023-11-14
Merck KGaA. (11/14/23). "Press Release: Merck Announces Plans for New U.S. Healthcare Headquarters in Boston’s Seaport District [Not intended for US-based media]". Darmstadt. 2023-11-14
Glox Therapeutics Ltd.. (11/14/23). "Press Release: Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria". Glasgow. 2023-11-14
ViaNautis Bio Ltd.. (11/13/23). "Press Release: ViaNautis Bio Announces $25 Million Series A Financing to Drive the Next Generation of Genetic Nanomedicines". Cambridge. 2023-11-13
Legend Biotech Corporation. (11/13/23). "Press Release: Legend Biotech Announces Exclusive, Global License Agreement for Certain CAR-T Therapies Targeting DLL3". Somerset, NJ. 2023-11-13
SwiftPharma B.V.. (11/13/23). "Press Release: SwiftPharma and PlantForm Corporation Target Blockbuster Cancer Drug with New Contract Manufacturing Agreement for Plant-made Biosimilars". Ghent & Toronto, ON. 2023-11-13
Bico Group AB. (11/13/23). "Press Release: BICO Has Divested Ginolis through a Management Buy-out to Ginolis’ Current CEO Kauko Väinämö. The Purchase Price amounted to €1". 2023-11-13
Bico Group AB. (11/13/23). "Press Release: Maria Forss Assumes Office as BICO’s CEO and President on November 20, 2023". 2023-11-13
VectorY Therapeutics B.V.. (11/13/23). "Press Release: VectorY Raises €129 Million ($138 Million) Series A Financing to Advance Vectorized Antibody Programs in Neurodegenerative Diseases". Amsterdam. 2023-11-13
Valneva S.E.. (11/10/23). "Press Release: Valneva Announces U.S. FDA Approval of World’s First Chikungunya Vaccine, Ixchiq". Saint Herblain. 2023-11-10
Insempra GmbH. (11/10/23). "Press Release: Insempra Wins €1.5M Disruptive Innovation Grant with Circular Biomanufacturing Concept »BioTreasure«". Munich. 2023-11-10
Cromatic Inc.. (11/9/23). "Press Release: Cromatic Closes $5.3 Million in Oversubscribed Seed Round to Modernize Life Science R&D Outsourcing". Palo Alto, CA. 2023-11-09
Mainz Biomed N.V.. (11/9/23). "Press Release: Mainz Biomed Partners with Liquid Biosciences to Harness the Power of Artificial Intelligence (AI) to Develop Next-generation Colorectal Screening Test". Berkeley, CA & Mainz. 2023-11-09
Valneva S.E.. (11/9/23). "Press Release: Valneva Reports Nine-Month 2023 Financial Results and Provides Corporate Updates". Saint Herblain. 2023-11-09
OpGen, Inc.. (11/7/23). "FORM 8-K: OpGen’s Wholly Owned Subsidiaries Curetis GmbH and Ares Genetics GmbH Filed for Bankruptcy Protection". 2023-11-07
Valneva S.E.. (11/7/23). "Press Release: Valneva to Present and Hold Investor Meetings at the Jefferies London Healthcare Conference". Saint Herblain. 2023-11-07
Kynexis B.V.. (11/7/23). "Press Release: Kynexis Launched to Advance Precision Therapeutics for Brain Diseases". Naarden. 2023-11-07
Valanx Biotech GmbH. (11/7/23). "Press Release: Valanx Biotech Announces Successful Fundraise of 2.3 M EUR". Klosterneuburg. 2023-11-07
Immunic, Inc.. (11/2/23). "Press Release: Immunic Receives Notice of Allowance for United States Patent Protecting the Treatment of Relapsing Multiple Sclerosis with Vidofludimus and Its Salts". New York, NY. 2023-11-02
Memo Therapeutics AG. (11/02/23). "Press Release: Memo Therapeutics AG Raises CHF 25 Million Series C Financing to Complete Phase II Clinical Development of AntiBKV for BKV Infection in Renal Transplant Patients". Schlieren. 2023-11-02 AG. (11/02/23). "Press Release: Raises € 4.5 Million in Pre-Series A Financing to Drive Development of Organoid Screening Platform for Cardiac Drug Discovery". Vienna. 2023-11-02
Cambrium GmbH. (11/1/23). "Press Release: Cambrium Secures €8 Million in Seed Funding to Commercialize New Class of Performance Molecules". 2023-11-01
LimFlow S.A.. (11/1/23). "Press Release: LimFlow Announces Agreement to Be Acquired by Inari Medical". Paris & San José, CA. 2023-11-01
Cellbox Solutions GmbH. (11/1/23). "Press Release: Dr. Hartmut Tintrup Joins Cellbox Solutions GmbH as new CEO". Cologne. 2023-11-01
BioNTech SE. (10/31/23). "Press Release: BioNTech to Present Clinical and Preclinical Data Updates Across Multiple Immuno-Oncology Programs at 2023 SITC Annual Meeting". Mainz. 2023-10-31
Danaher Corporation. (10/31/23). "Press Release: Danaher Appoints Christopher Riley to Executive Vice President for Biotechnology". Washington D.C.. 2023-10-31
AATec Medical GmbH. (10/31/23). "Press Release: AATec Medical and Beurer Enter Development Collaboration for Inhaled Alpha-1 Antitrypsin". Munich. 2023-10-31
Burning Rock Biotech Ltd.. (10/31/23). "Press Release: Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics". 2023-10-31
Abingworth LLP. (10/30/23). "Press Release: Abingworth Raises $356 Million for New Clinical Co-Development Co-Investment Fund (CCD-CIF)". London & New York, NY. 2023-10-30
Bicycle Therapeutics plc. (10/30/23). "Press Release: Bicycle Therapeutics to Participate in Upcoming Investor Conferences". Cambridge. 2023-10-30
MeiraGTx Holdings plc. (10/30/23). "Press Release: MeiraGTx Announces $30 Million Strategic Investment from Sanofi; Company Pursuing Multiple Additional Strategic Opportunities". London & New York, NY. 2023-10-30
Roche. (10/30/23). "Press Release: Roche Announces EMBARK Trial in Duchenne Muscular Dystrophy (DMD) Did Not Reach Primary Endpoint, but Shows Positive Efficacy Outcomes on All Timed Functional Key Endpoints". Basel. 2023-10-30
Merck KGaA. (10/30/23). "Press Release: Merck Strengthens Oncology Pipeline Through Strategic Partnership with Hengrui for Next-Generation Selective PARP1 Inhibitor and Antibody-Drug Conjugate [Not intended for US-, Canada- or UK-based media]". Darmstadt 2023-10-30
Santhera Pharmaceuticals Holding AG. (10/27/23). "Press Release: Santhera Receives U.S. FDA Approval of AGAMREE® (vamorolone) for the Treatment of Duchenne Muscular Dystrophy [Ad hoc announcement pursuant to Art. 53 LR]". Pratteln. 2023-10-27
Mainz Biomed N.V.. (10/26/23). "Press Release: Mainz Biomed Appoints Tarrin Khairi-Taraki as VP of Commercial Operations". Berkeley, CA & Mainz. 2023-10-26
Paion AG. (10/26/23). "Press Release: Filing an Application for the Opening of Insolvency Proceedings [ad hoc]". Aachen. 2023-10-26
Simbec-Orion. (10/26/23). "Press Release: Simbec-Orion and Launch Strategic Partnership to De-risk Early-stage Drug Development with AI Supported Clinical Trial Design". London. 2023-10-26
Valneva S.E.. (10/25/23). "Press Release: Valneva Submits Chikungunya Vaccine Marketing Application to EMA and Announces CHMP Accelerated Assessment". Saint Herblain. 2023-10-25
MetrioPharm AG. (10/25/23). "Press Release: MetrioPharm Receives Rare Pediatric Disease Designation (RPDD) for MP1032 from the U.S. FDA". Zurich. 2023-10-25
Abivax S.A.. (10/24/23). "Press Release: Abivax Announces Closing of its Initial Public Offering on the Nasdaq Global Market". Paris. 2023-10-24
Caris Life Sciences Inc.. (10/24/23). "Press Release: Caris Life Sciences and Moderna Announce Multi-Year Strategic Partnership to Advance mRNA-Based Oncology Therapeutics". Irving, TX. 2023-10-24
OrbiMed Advisors LLC. (10/24/23). "Press Release: OrbiMed Raises $4.3 Billion Across Private Investment Funds". New York, NY. 2023-10-24
Immatics N.V.. (10/24/23). "Press Release: Immatics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ACTengine® IMA203 TCR-T Monotherapy". Houston, TX & Tübingen. 2023-10-24
High-Tech Gründerfonds Management GmbH. (10/23/23). "Press Release: FarmInsect Raises Oversubscribed €8m Series A to Commercially Scale Its Insect Farming Technology". Munich. 2023-10-23
CMBlu Energy AG. (10/23/23). "Press Release: Technology Group STRABAG Invests 100 Million Euros into Battery and Energy Storage Company CMBlu Energy". Alzenau. 2023-10-23
Nanoform Finland Oyj. (10/23/23). "Press Release: Nanoform Grant Global Starmap AI License to AstraZeneca". Helsinki. 2023-10-23
Roche. (10/23/23). "Press Release: Roche Enters into a Definitive Agreement to Acquire Telavant". Basel. 2023-10-23
Abivax S.A.. (10/20/23). "Press Release: Abivax Announces the Pricing of Its Initial Public Offering on the Nasdaq Global Market". Paris. 2023-10-20
GSK plc. (10/20/23). "Press Release: GSK Enters Exclusive License Agreement with Hansoh for HS-20089". London. 2023-10-20
Global Bioenergies S.A.. (10/19/23). "Press Release: Global Bioenergies Announces the Appointment of Martin Stephan as Chief Business Officer". Evry. 2023-10-19
bioMérieux S.A.. (10/19/23). "Press Release: bioMérieux Makes Strategic Investment in Oxford Nanopore". Oxford & Marcy-l’Etoile. 2023-10-19
Merck & Co., Inc.. (10/19/23). "Press Release: Daiichi Sankyo and Merck Announce Global Development and Commercialization Collaboration for Three Daiichi Sankyo DXd ADCs". Basking Ridge, NJ & Rahway, NJ. 2023-10-19
Cresset Biomolecular Discovery Ltd.. (10/18/23). "Press Release: Cresset Targets International Growth with Innovate UK Scaleup Programme". Cambridge. 2023-10-18
4SC AG. (10/18/23). "Press Release: 4SC Receives Orphan Drug Designation (ODD) for Resminostat (Kinselby) in CTCL in the European Union". Planegg-Martinsried. 2023-10-18
4D Lifetec AG. (10/18/23). "Press Release: 4D Lifetec Secures CHF 23.3 Mio in a Share and Investment Deal with Xlife Sciences Opening New Horizons in Using AI and Digital Health in Early Cancer Detection". Zürich & Cham. 2023-10-18
BioCopy AG. (10/17/23). "Press Release: BioCopy and Yumab Announce Partnership for Development of Innovative safeTY-engager Platform". Emmendingen & Braunschweig. 2023-10-17
Exscientia plc. (10/17/23). "Press Release: Parker Moss to Join Exscientia as EVP, Corporate Development". Oxford. 2023-10-17
Owkin. (10/17/23). "Press Release: Servier Partners with Owkin with the Aim of Discovering and Developing AI-driven Precision Therapeutics". 2023-10-17
1 2 3 ... 96 97 98  next pagenext page


Picture EBD Group Biotech Showcase 2024 San Francisco 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group Biotech Showcase 2024 San Francisco 650x300px

» top